Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00244309 | Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer | PHASE3 | COMPLETED | 348 | — | — | Nov 1, 2005 | Jun 1, 2006 | May 4, 2011 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| tamsulosin and/or dutasteride | DRUG | - |
Inclusion Criteria: * Patient is eligible for a prostate implant * Patient is greater than 18 years of age * Patient is able to give informed consent * Patient does not currently take Flomax, Dutasteride or Finasteride * Patient does not have a known hypersensitivity reaction to Flomax or Dutasteri...